RESUMO
Chronic intestinal inflammations are triggered by genetic and environmental components. However, it remains unclear how specific changes in the microbiota, host immunity, or pathogen exposure could promote the onset and exacerbation of these diseases. Here, we evaluated whether Salmonella enterica serovar Typhimurium (S. Typhimurium) infection increases the susceptibility to develop intestinal inflammation in mice. Two mouse models were used to evaluate the impact of S. Typhimurium infection: the chemical induction of colitis by dextran sulfate sodium (DSS) and interleukin (IL)-10-/- mice, which develop spontaneous intestinal inflammation. We observed that S. Typhimurium infection makes DSS-treated and IL-10-/- mice more susceptible to develop intestinal inflammation. Importantly, this increased susceptibility is associated to the ability of S. Typhimurium to persist in liver and spleen of infected mice, which depends on the virulence proteins secreted by Salmonella Pathogenicity Island 2-encoded type three secretion system (TTSS-2). Although immunization with a live attenuated vaccine resulted in a moderate reduction of the IL-10-/- mice susceptibility to develop intestinal inflammation due to previous S. Typhimurium infection, it did not prevent bacterial persistence. Our results suggest that persistent S. Typhimurium infection may increase the susceptibility of mice to develop inflammation in the intestine, which could be associated with virulence proteins secreted by TTSS-2.
Assuntos
Proteínas de Bactérias/imunologia , Colite/imunologia , Predisposição Genética para Doença , Interleucina-10/deficiência , Intestinos , Proteínas de Membrana/imunologia , Infecções por Salmonella , Salmonella typhimurium , Animais , Proteínas de Bactérias/genética , Colite/genética , Colite/microbiologia , Colite/patologia , Sulfato de Dextrana/toxicidade , Inflamação/induzido quimicamente , Inflamação/genética , Inflamação/imunologia , Inflamação/microbiologia , Interleucina-10/imunologia , Intestinos/imunologia , Intestinos/patologia , Proteínas de Membrana/genética , Camundongos , Camundongos Knockout , Infecções por Salmonella/genética , Infecções por Salmonella/imunologia , Infecções por Salmonella/patologia , Salmonella typhimurium/imunologia , Salmonella typhimurium/patogenicidade , Fatores de Virulência/genética , Fatores de Virulência/imunologiaRESUMO
Inflammatory bowel disease (IBD) includes a set of pathologies that result from a deregulated immune response that may affect any portion of the gastrointestinal tract. The most prevalent and defined forms of IBD are Crohn's disease and ulcerative colitis. Although the etiology of IBD is not well defined, it has been suggested that environmental and genetic factors contribute to disease development and that the interaction between these two factors can trigger the pathology. Diet, medication use, vitamin D status, smoking, and bacterial infections have been proposed to influence or contribute to the onset or development of the disease in susceptible individuals. The infection with pathogenic bacteria is a key factor that can influence the development and severity of this disease. Here, we present a comprehensive review of studies performed in human and mice susceptible to IBD, which supports the notion that infection with bacterial pathogens, such as Salmonella, could promote the onset of IBD due to permanent changes in the intestinal microbiota, disruption of the epithelial barrier and alterations of the intestinal immune response after infection.